Advertisement
Advertisement
DTIL
Precision BioSciences, Inc. Common Stock
6.84
USDSponsored
+0.10
+1.45%
Jun 25, 10:02 UTC -4
Open
DTIL Earnings Reports
Positive Surprise Ratio
DTIL beat 16 of 29 last estimates.
55%
Next Report
Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$1.15M
/-$0.80
Implied change from Q1 26 (Revenue/ EPS)
-89.41%
/+6.67%
Implied change from Q2 25 (Revenue/ EPS)
+6275.00%
/-62.44%
Precision BioSciences, Inc. Common Stock earnings per share and revenue
On May 05, 2026, DTIL reported earnings of -0.75 USD per share (EPS) for Q1 26, missing the estimate of -0.66 USD, resulting in a -12.26% surprise. Revenue reached 10.84 million, compared to an expected 4.13 million, with a 162.36% difference. The market reacted with a -2.36% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 3 analysts forecast an EPS of -0.80 USD, with revenue projected to reach 1.15 million USD, implying an increase of 6.67% EPS, and decrease of -89.41% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
FAQ
What were Precision BioSciences, Inc. Common Stock's earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Precision BioSciences, Inc. Common Stock reported EPS of -$0.75, missing estimates by -12.26%, and revenue of $10.84M, 162.36% above expectations.
How did the market react to Precision BioSciences, Inc. Common Stock's Q1 2026 earnings?
The stock price moved down -2.36%, changed from $7.63 before the earnings release to $7.45 the day after.
When is Precision BioSciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for Aug 05, 2026.
What are the forecasts for Precision BioSciences, Inc. Common Stock's next earnings report?
Based on 3
analysts, Precision BioSciences, Inc. Common Stock is expected to report EPS of -$0.80 and revenue of $1.15M for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement